EUVIMEDEUVIMED entdecken
Open Access

SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC

Fengxiao An, Wenjing Zhang, Yuxian Guo, Fuyan Shi, Yujia Kong, Liguo Tang, Caijing Han, Qinghua Wang

Aging · 2023

DOI: 10.18632/aging.204913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Fengxiao An und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Immunological, Melanoma. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic Agents, ImmunologicalMelanomaHumansImmune Checkpoint InhibitorsMutationBiomarkers, TumorCarrier ProteinsNuclear Proteins

Stichwörter der Autor:innen

ICI treatmentNSCLCSETBP1 mutationclinical biomarkermelanoma

Substanzen

Immune Checkpoint InhibitorsAntineoplastic Agents, ImmunologicalBiomarkers, TumorSETBP1 protein, humanCarrier ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong, China.
  • Department of Health Statistics, Key Laboratory of Medicine and Health of Shandong Province, School of Public Health, Weifang Medical University, Weifang 261053, Shandong, China.
  • Department of Orthopedics, Sunshine Union Hospital, Weifang 261061, Shandong, China.
  • School of Public Health, Weifang Medical University, Weifang 261053, Shandong, China.

Zitieren

APA

An, F., Zhang, W., Guo, Y., Shi, F., Kong, Y., Tang, L., Han, C., & Wang, Q. (2023). SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC. Aging. https://doi.org/10.18632/aging.204913

Vancouver

An F, Zhang W, Guo Y, Shi F, Kong Y, Tang L, et al. SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC. Aging. 2023. doi:10.18632/aging.204913

BibTeX
@article{An2023,
  author = {An, Fengxiao and Zhang, Wenjing and Guo, Yuxian and Shi, Fuyan and Kong, Yujia and Tang, Liguo and Han, Caijing and Wang, Qinghua},
  title = {SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204913}
}
Kostenlos starten →